Plasminogen activator inhibitor type 1 biosynthesis and mRNA level are increased by dexamethasone in human fibrosarcoma cells

Mol Cell Biol. 1987 Aug;7(8):3021-5. doi: 10.1128/mcb.7.8.3021-3025.1987.

Abstract

Dexamethasone increases type 1 plasminogen activator inhibitor (PAI-1) activity released from the human fibrosarcoma cell line HT-1080. We demonstrated that dexamethasone caused about 10-fold increases in the intracellular and extracellular levels of PAI-1 protein, as measured by an enzyme-linked immunosorbent assay, in the rate of PAI-1 biosynthesis, and in the PAI-1 mRNA level. The effects on PAI-1 biosynthesis and mRNA level were detectable within 4 h and were maximal 16 to 24 h after the addition of dexamethasone. Cycloheximide did not inhibit the dexamethasone-induced increases in the capacity of the cells to synthesize PAI-1 and in the PAI-1 mRNA level.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line
  • Cycloheximide / pharmacology
  • Dexamethasone / pharmacology*
  • Fibrosarcoma / metabolism
  • Humans
  • Kinetics
  • Molecular Weight
  • RNA, Messenger / drug effects
  • RNA, Messenger / genetics*
  • Tissue Plasminogen Activator / biosynthesis*
  • Tissue Plasminogen Activator / genetics
  • Tissue Plasminogen Activator / isolation & purification

Substances

  • RNA, Messenger
  • Dexamethasone
  • Cycloheximide
  • Tissue Plasminogen Activator